EFTA00368780.pdf

From: "James Meiskin" To: "' Subject: RE: Confidential Date: Mon, 02 Jun 2014 14:11:08 +0000 Hi M, If we can meet Jeffrey before the 15th of June. it would be highly appreciated. Best Always, James From: [mailto 1 Sent: Thursday, May 29, 2014 10:02 AM To: James Meiskin Subject: Re: Confidential James, I am so sorry to do this, but Jeffrey must cancel his appointment with you and David Carter on Sunday June l...he is ill and says he will reschedule for later in the month... Once again, so sorry for any inconvenience. On May 21, 2014, at 6:05 PM, James Meiskin wrote: Confirmed. Thank you Sent from my iPhone On May 21, 2014, at 5:51 PM, > wrote: Jeffrey's home, 9 East 71st Street between 5th and Madison... 5pm would be great. On May 21, 2014, at 5:14 PM, James Meiskin al lna> wrote: EFTA00368780 That will work. Do you have a time and location in mind? Thank you, James Sent from my iPhone On May 21, 2014, at 10:25 AM, r> wrote: Great. Would Sunday June 1st work? Sent from my iPhone On May 21, 2014, at 9:47 AM, James Meiskin < wrote: Of course. Please get me dates that work for Jeffrey, and I will have David fly in from CA to meet him with pleasure. Hope your we Best, James Sent from my iPhone On May 21, 2014, at 9:41 AM, > wrote: HI James....below is Jeffrey's response: im not in ny until june but happy to see you both after Might it be possible to schedule something the beginning of June? On May 21. 2014, at 9:23 AM. "James Meiskin" > wrote: Jeffrey, David Carter (Company information is attached), is in NY today and tomorrow morning, and I felt that it could be beneficial and timely for you to further leam about this opportunity if there was interest on your end. Please take a moment to review the attached material. and let me know if you would like to meet while David is in NYC. Best Regards, James Dear James, EFTA00368781 Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their country. For their investment they get commercialization rights to the technologies they finance for Russia and the CIS. For us, on the USA side, this is a major source of capital to start a series of companies that have great potential as therapeutic technologies, and we get commercialization rights for the USA, and rest of the world markets. Basically, we get the rights that are valuable to us at "half price". Over the next several years our plan is to identify seven/eight technologies that are worthy of development. RVC has already agreed to finance the first (MAJI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capital that thinks this is an interesting investment theme, and is willing to consider the idea as something they might want to implement. My belief is that there is more money in NYC, seeking an investment home, then there are "quality investment ideas". I could be wrong, but I have to believe that people running a lot of capital in New York would want to hear new, creative, and GOOD new investment ideas. I think this idea is the kind of idea that is worth a look, and worth serious consideration. I think we are talking $150M over a five year horizon. Best, David David W. Carter President—DaCart Capital LLC <DaCart Presentation.pptx> EFTA00368782